This site is intended for healthcare professionals

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Pharmacological treatment options for moderate or greater severity COPD

Pharmacological treatment options for moderate or greater severity COPD

Format

Knowledge

Published

November 9, 2018

Updated

November 9, 2018

Program Description

Review the pharmacological options available to treat COPD, including the evidence base supporting their use.

Educational Objectives

After this activity, healthcare professionals will be better able to:
  • Recall the pharmacological approaches to COPD management
  • Understand the role of tiotropium, the LAMA of choice for COPD
  • Disclosure

    Initiated, funded and reviewed by Teva
    Date of preparation: October 2018; UK/BRA/18/0015

    Author

    Clara Anderson, locum pharmacist

    Instructions

    This is an industry-supported learning activity provided by MIMS Learning, featuring learning material and a test. Completing the test enables you to claim 0.25 learning credits (15 minutes learning). This credit award is recommended by MIMS Learning based on completing the activity and reflecting on what you have learned. If you spend less time on the activity we recommend claiming fewer credits.

    Please proceed with the activity until you have successfully answered all the test questions and completed your evaluation. You will then receive your MIMS Learning CPD certificate, which will be added to your CPD organiser for access at any time. This activity is offered at no cost.

    SYSTEM REQUIREMENTS

    Hardware and Software Requirements
    • A computer with an internet connection
    • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
    • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
    Add to Queue


    Related to this activity

    Prevalence and impact of COPD Knowledge

    Prevalence and impact of COPD

    0.25 Credits
    Initiated, funded and reviewed by Teva. Date of preparation: Date of preparation: October 2018; UK/BRA/18/0015
    Prescribing information for BraltusĀ® (tiotropium bromide) Inhalation Powder can be found here (PDF 68KB).